OGRD Alliance L.L.C-FZ expands its PLPC-DB phospholipoproteomic module from Dubai to Asia and the MENA region, strengthening its position as a bridge between American scientific innovation and global life-science investment. The initiative follows licensing frameworks, international exposure, and strategic agreements in Japan and Singapore. The PLPC Platform integrates scientific, regulatory, and validation pillars for adaptive biotechnology, nutritional technology, and real-world evidence compliance. The OncoVix Program demonstrates measurable and reproducible outcomes meeting global biotech standards. Dr. Ramón Gutiérrez Sandoval, Founder and Chief Scientific Officer of OGRD Alliance, emphasizes ethics, evidence, and scalability in data-driven innovation transcending borders. The PLPC Platform’s asset-licensing process is supported by leading UAE legal firms and banking brokers for regulatory transparency in strategic transactions. OGRD Alliance is dedicated to responsible innovation in non-cellular immunobiological platforms, integrating science, ethics, and traceability for global deployment.

Read more at Yahoo Finance: OGRD Alliance Expands OncoVix and PLPC-DB Initiatives from the Emirates to Asia and MENA Regions